期刊文献+

门冬氨酸鸟氨酸联合纳洛酮治疗肝性脑病

Ornithine Aspartate Combined with Naloxone in the Treatment of Hepatic Encephalopathy
下载PDF
导出
摘要 目的分析门冬氨酸鸟氨酸联合纳洛酮在肝性脑病治疗中的应用效果及对患者肝脏功能、生化指标的影响。方法选取2015年1月至2019年1月安徽省濉溪县医院收治的肝性脑病患者60例,随机平分为两组,对照组在常规治疗的基础上使用纳洛酮进行治疗,观察组在对照组治疗的基础上使用门冬氨酸鸟氨酸进行治疗,比较两组患者治疗效果、治疗前后肝脏功能、生化指标水平。结果观察组治疗有效率为93.33%,显著高于对照组(80.00%,P<0.05);观察组治疗后ALT、TBIL和γ-GT水平均明显优于对照组(P<0.05);观察组治疗后血氨水平和β-EP水平均明显低于对照组(P<0.05)。结论门冬氨酸鸟氨酸联合纳洛酮可有效提高肝性脑病治疗效果,对于改善患者的肝脏功能、生化指标水平效果显著,值得推广应用。 Objective To analyze the effect of ornithine aspartate combined with naloxone in the treatment of hepatic encephalopathy and its effect on liver function and biochemical indexes.Methods From January 2015 to January 2019,60 patients with hepatic encephalopathy treated in Suixi County Hospital of Anhui Province were randomly divided into two groups.The control group was treated with naloxone on the basis of routine treatment.The observation group was treated with ornithine aspartate on the basis of treatment in the control group.The therapeutic effect,liver function and biochemical index level before and after treatment were compared between the two groups.Results The effective rate of treatment in the observation group was 93.33%.After treatment,the levels of ALT,TBIL and gamma-GT in the observation group were significantly better than those in the control group(P<0.05),and the levels of blood ammonia andβ-EP in the observation group were significantly lower than those in the control group after treatment(P<0.05).Conclusion Aspartic acid ornithine combined with naloxone can effectively improve the therapeutic effect of hepatic encephalopathy,and it is worth popularizing and applying to improve the liver function and biochemical index level of patients.
作者 薛杰 XUE Jie(Anhui Suixi County Hospital,Huaibei,Anhui 235100,China)
出处 《大医生》 2019年第4期108-109,114,共3页 Doctor
关键词 肝性脑病 纳洛酮 门冬氨酸鸟氨酸 hepatic encephalopathy naloxone ornithine aspartate
  • 相关文献

参考文献4

二级参考文献42

  • 1李晓青,董蕾,刘中华,罗金燕.肝性脑病大鼠GABA-A受体亚单位mRNA的表达[J].中华肝脏病杂志,2005,13(3):232-233. 被引量:1
  • 2肖红德.纳洛酮联合精氨酸治疗肝硬化并发肝性脑病的疗效观察[J].中国医师杂志,2005,7(5):709-710. 被引量:6
  • 3王世伟,何平,田文广,何渝,丁静.纳络酮注射液治疗137例肝性脑病的临床疗效观察[J].重庆医学,2006,35(22):2070-2070. 被引量:5
  • 4叶任高,陆再英,钟南山.内科学[M].第7版,北京:人民卫生出版社,2010:463.
  • 5Dbouk N, McGuire BM. Hepatic encephalopathy: a review of its patho- physiology and treatment [ J ]. Curr Treat Options Gastreenterol, 2006,9 (6) :464 -474.
  • 6Jiang Q, Jiang G, Welty TE, et al. Naloxone in the management of he- patic encephalopathy[ J]. J Clin Pharm Ther, 2010,35(3) :333 -341.
  • 7Jain L, Sharma BC, Sharma P, et al. Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy. Dig Liver Dis, 2012, 44: 1027-1031.
  • 8Parker T, Freilich S, Tidswell T, et al. Hepatic encephalopathy with epilepsia partialis continua: a case report. Seizure, 2012, 21: 813-815.
  • 9Seo YS, Vim SY, Jung JY, et al. Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis. J Gastroenterology Hepatol, 2012, 27: 1695-1704.
  • 10Corbett C, Mangat K, Olliff S, et al. The role of Transjugular Intrahepatic Portosystemic Stent-Shunt(TIPSS) in the management of variceal hemorrhage. Liver Int, 2012, 32: 1493-1504.

共引文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部